Oncology Letters Journal Citation Rate 2026

ISSN 1792-1074 eISSN 1792-1082 Spandidos Publishing GR

Q2 Quartile Open Access

About Oncology Letters
{# Self-contained "answer block": one dense, LLM-quotable paragraph stating every core fact with an explicit as-of year, server-rendered and unique per journal. This is the canonical fact statement — other sections add narrative, they do not restate these numbers. #}

Oncology Letters (OL) is a peer-reviewed academic journal, published by Spandidos Publishing in GR, catalogued under ISSN 1792-1074 (e-ISSN 1792-1082). As of 2026, it has a 2025 2-Year Citation Rate (OpenAlex) of 1.86 (Q2 quartile) — the average number of citations its recent articles received over a two-year window, computed from OpenAlex open citation data, not the Clarivate (JCR) Impact Factor. It is fully open access.

Oncology Letters Citation Rate 2026 — In Context

Oncology Letters has a 2025 2-Year Citation Rate (OpenAlex) of 1.86, placing it in the Q2 quartile. This is the average number of citations the journal's recent articles received over a two-year window, computed from OpenAlex open citation data — not the Clarivate (JCR) Journal Impact Factor.

As a fully open-access publication, Oncology Letters makes all articles freely available to readers.

Researchers looking to publish in Oncology Letters should review the journal's submission tips and verify the latest indexing status against Scopus, DOAJ, and Web of Science using our indexing tracker. To compare Oncology Letters against similar journals in the field, use our journal comparison tool.

ISSN (Print) 1792-1074
ISSN (Online) 1792-1082
Publisher Spandidos Publishing
Country Greece
APC / Cost Inquire with Publisher
In-depth profile & metrics

Oncology Letters is published by Spandidos Publishing and based in Greece. It publishes on an open-access basis.

Oncology Letters is indexed in OpenAlex. OpenAlex tracking provides an open, citable record of its output even where commercial indexing is absent.

Its most recent citation rate stands at 1.857.

Links
Frequently Asked Questions about Oncology Letters

Oncology Letters does not hold a Clarivate (JCR) Impact Factor on JournalsHub. Its 2-year citation rate, computed from OpenAlex open citation data, is 1.857 — an open proxy for citation impact, not the licensed JCR Impact Factor.

Yes, Oncology Letters is an open access journal.

Oncology Letters is published by Spandidos Publishing.

Oncology Letters shows strong legitimacy signals: it is indexed in DOAJ, OpenAlex. Indexing in recognised databases such as Scopus and DOAJ is a reliable indicator of a peer-reviewed, non-predatory journal, because predatory titles are typically excluded from them. Always confirm the journal's scope and editorial board fit your work before submitting.

The ISSN of Oncology Letters is 1792-1074. Its electronic ISSN (eISSN) is 1792-1082.

Oncology Letters sits in the Q2 quartile based on its latest impact factor of 1.86, ranked across all journals in our database.
Live Indexing Status
Updated April 2026

Track real-time indexing metrics to ensure this journal meets your academic requirements.

OpenAlex
Verified
DOAJ
Indexed OA
Predatory Check
Clean
Citation Rate
1.857
2-Year Citation Rate (OpenAlex) · 2025
Historical Trend
Initial data points only
Citation Rate by Year
Year Value Source
2025 1.857 2-Year Mean Citedness (OpenAlex)

Metrics are sourced from OpenAlex, DOAJ and Scopus and reflect the latest data we hold. The headline figure is a 2-year citation rate (OpenAlex), not a Clarivate Impact Factor. Always verify against the journal's official site before relying on it. See our Methodology or report a correction.

Metadata

Last updated: Apr 24, 2026

Updated by: openalex_bulk

OpenAlex ID: S58832373

Get weekly updates

Free. Monday morning. New citation rates, CFPs, indexing alerts, predatory watch list. One-click unsubscribe.

Comparison Shortlist
0 journals
Est. APC Budget: $0
Compare Now
Compare 0 Open → Clear
Save your viewing history
You've browsed several journals this session. Sign in to track them in one place and get weekly impact-factor updates.
Save with Google